LivaNova (NAS: LIVN)

LivaNova is a corporation based in London, United Kingdom. Established in 2015, the firm was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. The firm derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world. The firm's assets are managed by the board of directors.